Literature DB >> 29058295

Effects of high frequency repetitive transcranial magnetic stimulation on KCC2 expression in rats with spasticity following spinal cord injury.

Wei Gao1, Li-Guo Yu2, Ya-Li Liu3, Mo Chen2, Yi-Zhao Wang2, Xiao-Lin Huang2.   

Abstract

The effect of high-frequency repetitive transcranial magnetic stimulation (rTMS) on potassium- chloride cotransporter-2 (KCC2) protein expression following spinal cord injury (SCI) and the action mechanism were investigated. SCI models were established in SD rats. Five groups were set up randomly: normal control group, SCI 7-day (7D) model group, SCI 14-day (14D) model group, SCI-7D rTMS group and SCI-14D rTMS group (n=5 each). The rats in SCI rTMS groups were treated with 10 Hz rTMS from 8th day and 15th day after SCI respectively, once every day, 5 days every week, a total of 4 weeks. After the model establishment, motor recovery and spasticity alleviation were evaluated with BBB scale once a week till the end of treatment. Finally, different parts of tissues were dissected out for detection of variations of KCC2 protein using Western blotting and polymerase chain reaction (PCR) technique. The results showed that the BBS scores after treatment were significantly higher in SCI-7D rTMS group than in SCI-14D rTMS group (P<0.05). As compared with normal control groups, The KCC2 protein in SCI model groups was down-regulated after SCI, and the decrease was much more significant in SCI-14D model group than in SCI-7D group (P<0.05). As compared with SCI model groups, KCC2 protein in rTMS groups was up-regulated after the treatment (P<0.05). The up-regulation of KCC2 protein content and expression was more obvious in SCI-7D rTMS group than in SCI-14D rTMS group (P<0.05). It was concluded that 10 Hz rTMS can alleviate spasticity in rats with SCI, which might be attributed to the up-regulation of KCC2 protein. It was also suggested that the high-frequency rTMS treatment after SCI at early stage might achieve more satisfactory curative effectiveness.

Entities:  

Keywords:  potassium-chloride cotransporter-2; repetitive transcranial magnetic stimulation; spasticity; spinal cord injury

Mesh:

Substances:

Year:  2017        PMID: 29058295     DOI: 10.1007/s11596-017-1804-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  17 in total

1.  Mechanism of GABA receptors involved in spasticity inhibition induced by transcranial magnetic stimulation following spinal cord injury.

Authors:  Wei Gao; Li-Guo Yu; Ya-Li Liu; Yi-Zhao Wang; Xiao-Lin Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

2.  Short-interval intracortical inhibition with incomplete spinal cord injury.

Authors:  François D Roy; Ephrem Takele Zewdie; Monica A Gorassini
Journal:  Clin Neurophysiol       Date:  2011-02-03       Impact factor: 3.708

3.  Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte.

Authors:  Hoau-Yan Wang; Domenica Crupi; Jingjing Liu; Andres Stucky; Giuseppe Cruciata; Alessandro Di Rocco; Eitan Friedman; Angelo Quartarone; M Felice Ghilardi
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

4.  Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury.

Authors:  Pascale Boulenguez; Sylvie Liabeuf; Rémi Bos; Hélène Bras; Céline Jean-Xavier; Cécile Brocard; Aurélie Stil; Pascal Darbon; Daniel Cattaert; Eric Delpire; Martin Marsala; Laurent Vinay
Journal:  Nat Med       Date:  2010-02-28       Impact factor: 53.440

5.  Motor and gait improvement in patients with incomplete spinal cord injury induced by high-frequency repetitive transcranial magnetic stimulation.

Authors:  J Benito; H Kumru; N Murillo; U Costa; J Medina; J M Tormos; Alvaro Pascual-Leone; J Vidal
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

6.  Posttraumatic GABA(A)-mediated [Ca2+]i increase is essential for the induction of brain-derived neurotrophic factor-dependent survival of mature central neurons.

Authors:  Anastasia Shulga; Judith Thomas-Crusells; Thomas Sigl; Anne Blaesse; Pedro Mestres; Michael Meyer; Qiao Yan; Kai Kaila; Mart Saarma; Claudio Rivera; Klaus M Giehl
Journal:  J Neurosci       Date:  2008-07-02       Impact factor: 6.167

7.  Neurotrophic factors promote and enhance locomotor recovery in untrained spinalized cats.

Authors:  Vanessa S Boyce; Maureen Tumolo; Itzhak Fischer; Marion Murray; Michel A Lemay
Journal:  J Neurophysiol       Date:  2007-07-25       Impact factor: 2.714

8.  Intrathecal baclofen for autonomic instability due to spinal cord injury.

Authors:  Markus Kofler; Katharina Poustka; Leopold Saltuari
Journal:  Auton Neurosci       Date:  2009-01-20       Impact factor: 3.145

9.  Repetitive transcranial magnetic stimulation improves open field locomotor recovery after low but not high thoracic spinal cord compression-injury in adult rats.

Authors:  Anne-Lise Poirrier; Yves Nyssen; Felix Scholtes; Sylvie Multon; Charline Rinkin; Géraldine Weber; Delphine Bouhy; Gary Brook; Rachelle Franzen; Jean Schoenen
Journal:  J Neurosci Res       Date:  2004-01-15       Impact factor: 4.164

10.  Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats.

Authors:  Vanessa S Boyce; Jihye Park; Fred H Gage; Lorne M Mendell
Journal:  Eur J Neurosci       Date:  2011-12-30       Impact factor: 3.386

View more
  2 in total

1.  Effects of Repetitive Transcranial Magnetic Stimulation on Astrocytes Proliferation and nNOS Expression in Neuropathic Pain Rats.

Authors:  Lu Yang; Sai-Hua Wang; Yan Hu; Yan-Fang Sui; Tao Peng; Tie-Cheng Guo
Journal:  Curr Med Sci       Date:  2018-06-22

Review 2.  Stimulation Parameters Used During Repetitive Transcranial Magnetic Stimulation for Motor Recovery and Corticospinal Excitability Modulation in SCI: A Scoping Review.

Authors:  Nabila Brihmat; Didier Allexandre; Soha Saleh; Jian Zhong; Guang H Yue; Gail F Forrest
Journal:  Front Hum Neurosci       Date:  2022-04-07       Impact factor: 3.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.